Doc Generici

Milan, Italy Founded: 1996 • Age: 30 yrs Acquired By ICG
Generic pharmaceuticals and ophthalmology products are manufactured in Italy.
Request Access

About Doc Generici

DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.

  • Headquarter Milan, Italy
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Doc Pharma
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    CVC

    & 3 more

  • Employee Count
    Employee Count
  • Acquired by
    ICG

    & 2 more

    (Apr 08, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Doc Generici
Headcount 50-200
Employee Profiles 13
Employee Profiles
People
Sara Tumiotto
Senior Accountant
People
Alberto Villa
CFO
People
Silvia Lissoni
Technology Transfer Director
People
Riccardo Zagaria
CEO

Unlock access to complete

Funding Insights of Doc Generici

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Doc Generici

Doc Generici has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include CVC, ICG and Charterhouse Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are managed by Charterhouse Capital Partners.
Founded Year Domain Location
Mezzanine financing and equity investments are provided by CVC.
Founded Year Domain Location
ICG is recognized as a global alternative asset manager.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Doc Generici

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Doc Generici

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Doc Generici Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Doc Generici

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Doc Generici

Frequently Asked Questions about Doc Generici

When was Doc Generici founded?

Doc Generici was founded in 1996.

Where is Doc Generici located?

Doc Generici is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.

Who is the current CEO of Doc Generici?

Gualtiero Pasquarelli is the current CEO of Doc Generici.

What does Doc Generici do?

DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.

Who are Doc Generici's investors?

Doc Generici has 4 investors. Key investors include CVC, ICG, Charterhouse Capital Partners, and Merieux Equity Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available